
ECOR · NASDAQ
electroCore, Inc.
$8.42 +0.75 (+9.78%)
Company overview
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $75.9M
- Employees
- 73
- Headquarters
- Rockaway, NJ
- Website
- electrocore.com
- CEO
- Thomas J. Errico
- Listed
- June 22, 2018
- P/E
- -4.65
- Dividend yield
- 0.00%
Company financials
- Revenue
- $34.9M
- Gross profit
- $30.4M
- Operating income
- -$14.6M
- EBITDA
- -$13.4M
- Net income
- -$15.4M
- EPS
- -$1.81
- Total assets
- $15.5M
- Total debt
- $9.5M
- Gross margin
- 87.25%
- Net margin
- -44.08%
- Earnings yield
- -21.50%
No product segmentation.
Showing FY 2024